The Role of MRI Pancreatic Protocol in Assessing Response to Neoadjuvant Therapy for Patients With Borderline Resectable Pancreatic Cancer

The Role of MRI Pancreatic Protocol in Assessing Response to Neoadjuvant Therapy for Patients With Borderline Resectable Pancreatic Cancer

BackgroundBorderline Resectable Pancreatic Cancer (BRPC) remains a unique entity that is difficult to categorize due to variance in definitions and the small number of patients. The ultimate goal is to achieve a free resection (R0) after a favorable response to neoadjuvant therapy that is somewhat d...

Full description

Bibliographic Details
Main Authors: Nervana Hussien, Rasha S. Hussien, Darine Helmy Amin Saad, Mohamed El Kassas, Walid F. Elkhatib, Mai Ezz El Din
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
borderline resectable pancreatic cancer
ADC
radiological assessment
RECIST criteria
DWI-MRI
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.796317/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.796317/full

Similar Items